New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

Published Date: 31 Jul 2023

With a five-year survival rate of less than 20%, esophageal adenocarcinoma (EAC) is a highly fatal cancer. Despite being an EAC precursor lesion,.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

2.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

3.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

4.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

5.

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot